Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA440614
Max Phase: Preclinical
Molecular Formula: C66H98N14O13
Molecular Weight: 1295.60
Molecule Type: Protein
Associated Items:
ID: ALA440614
Max Phase: Preclinical
Molecular Formula: C66H98N14O13
Molecular Weight: 1295.60
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)C(C)C
Standard InChI: InChI=1S/C66H98N14O13/c1-38(2)30-50(76-58(84)46(69)32-42-20-10-8-11-21-42)59(85)71-36-55(82)73-53(34-44-35-70-47-25-15-14-24-45(44)47)63(89)77-51(31-39(3)4)61(87)78-52(33-43-22-12-9-13-23-43)62(88)74-48(26-16-18-28-67)60(86)80-56(40(5)6)65(91)72-41(7)57(83)79-54(37-81)64(90)75-49(66(92)93)27-17-19-29-68/h8-15,20-25,35,38-41,46,48-54,56,70,81H,16-19,26-34,36-37,67-69H2,1-7H3,(H,71,85)(H,72,91)(H,73,82)(H,74,88)(H,75,90)(H,76,84)(H,77,89)(H,78,87)(H,79,83)(H,80,86)(H,92,93)/t41-,46-,48-,49-,50-,51-,52-,53-,54-,56-/m0/s1
Standard InChI Key: GDPOQBKTEFETDS-TWEJCITDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1295.60 | Molecular Weight (Monoisotopic): 1294.7438 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Won HS, Seo MD, Jung SJ, Lee SJ, Kang SJ, Son WS, Kim HJ, Park TK, Park SJ, Lee BJ.. (2006) Structural determinants for the membrane interaction of novel bioactive undecapeptides derived from gaegurin 5., 49 (16): [PMID:16884301] [10.1021/jm050996u] |
Source(1):